XML 20 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Assets:    
Cash and cash equivalents $ 37,310 $ 37,168
Investments in securities:    
Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2022: $66,209; December 31, 2021: $75,511) 67,725 79,791
Equity securities, at fair value (cost: March 31, 2022: $28,484; December 31, 2021: $29,478) 69,945 76,853
Short-term investments 58,555 45,930
Other investments 20,217 20,298
Total investments 216,442 222,872
Premiums and fees receivable 23,850 22,953
Accrued interest and dividends 1,000 817
Prepaid expenses and other receivables 11,618 11,721
Property, net 13,413 13,033
Goodwill and other intangible assets, net 15,621 15,951
Operating lease right-of-use assets 7,321 5,202
Other assets 1,822 1,771
Total Assets 328,397 331,488
Liabilities:    
Reserve for claims 36,366 36,754
Accounts payable and accrued liabilities 34,486 43,868
Operating lease liabilities 7,453 5,329
Current income taxes payable 6,164 3,329
Deferred income taxes, net 11,436 13,121
Total liabilities 95,905 102,401
Commitments and Contingencies 0 0
Stockholders' Equity:    
Preferred stock (1,000 authorized shares; no shares issued) 0 0
Common stock – no par value (10,000 authorized shares; 1,897 and 1,895 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively, excluding in each period 292 shares of common stock held by the Company) 0 0
Retained earnings 231,274 225,861
Accumulated other comprehensive income 1,218 3,226
Total stockholders' equity 232,492 229,087
Total Liabilities and Stockholders’ Equity $ 328,397 $ 331,488